Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.623,18
0,21%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CalciMedica Inc (CALC) CalciMedica Inc (CALC) Notizie

CALC

CalciMedica (CALC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CALC
DataOraFonteTitoloSimboloCompagnia
13/05/202422:05PR Newswire (US)CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate UpdatesNASDAQ:CALCCalciMedica Inc
07/05/202414:00PR Newswire (US)CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024NASDAQ:CALCCalciMedica Inc
24/04/202414:00PR Newswire (US)CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute PancreatitisNASDAQ:CALCCalciMedica Inc
28/03/202412:00PR Newswire (US)CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate UpdatesNASDAQ:CALCCalciMedica Inc
13/03/202413:00PR Newswire (US)CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT ConferenceNASDAQ:CALCCalciMedica Inc
29/02/202400:57PR Newswire (US)CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT ConferenceNASDAQ:CALCCalciMedica Inc
13/02/202414:00PR Newswire (US)CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney InjuryNASDAQ:CALCCalciMedica Inc
07/02/202422:05PR Newswire (US)CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CALCCalciMedica Inc
22/01/202414:00PR Newswire (US)CalciMedica Announces Private Placement of up to Approximately $55 MillionNASDAQ:CALCCalciMedica Inc
09/11/202313:00PR Newswire (US)CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate UpdatesNASDAQ:CALCCalciMedica Inc
02/11/202314:15PR Newswire (US)CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & ExpositionNASDAQ:CALCCalciMedica Inc
06/09/202313:30PR Newswire (US)CalciMedica Announces Upcoming Presentations and Events in SeptemberNASDAQ:CALCCalciMedica Inc
31/08/202313:30PR Newswire (US)CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023NASDAQ:CALCCalciMedica Inc
10/08/202322:05GlobeNewswire Inc.CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate UpdatesNASDAQ:CALCCalciMedica Inc
09/08/202313:30GlobeNewswire Inc.CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)NASDAQ:CALCCalciMedica Inc
12/06/202313:30GlobeNewswire Inc.CalciMedica Announces Relisting on NasdaqNASDAQ:CALCCalciMedica Inc
06/06/202313:30GlobeNewswire Inc.CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)NASDAQ:CALCCalciMedica Inc
23/05/202313:30GlobeNewswire Inc.CalciMedica Expands Executive Team with New AppointmentsNASDAQ:CALCCalciMedica Inc
15/05/202314:55GlobeNewswire Inc.CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate UpdatesNASDAQ:CALCCalciMedica Inc
22/03/202321:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CALCCalciMedica Inc
20/03/202321:25GlobeNewswire Inc.CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private PlacementNASDAQ:CALCCalciMedica Inc
25/02/201101:34PR Newswire (US)California Coastal Communities Obtains Court Confirmation of Plan of ReorganizationNASDAQ:CALCCalciMedica Inc
12/01/201121:15PR Newswire (US)California Coastal Communities to Begin Solicitation of Creditors to Confirm Plan of Reorganization and Emerge From BankruptcyNASDAQ:CALCCalciMedica Inc
22/04/201018:33Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CALCCalciMedica Inc
22/04/201014:30PR Newswire (US)CALC Receives Final NASDAQ Determination to Suspend Its Stock From Trading on April 27, 2010NASDAQ:CALCCalciMedica Inc
12/04/201014:30PR Newswire (US)CALC Receives Nasdaq Determination to Delist its Stock From TradingNASDAQ:CALCCalciMedica Inc
22/03/201012:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CALCCalciMedica Inc
10/02/201023:03Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:CALCCalciMedica Inc
08/02/201016:45Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CALCCalciMedica Inc
30/12/200917:15PR Newswire (US)/C O R R E C T I O N -- California Coastal Communities, Inc./NASDAQ:CALCCalciMedica Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CALC

La tua Cronologia

TSXV
CPV
Copper Creek Gold Corp.
BIT
P1S3V1
NLBNPIT1S3V1 20241220 250
BIT
UIE205
Unicredit
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network